GlassScriptPhysician profile
Ivette Hernandez
NPI 1861066110
$1,666.28
in general payments reported to CMS, 2019-2025
15 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $261 · 2023: $647 · 2024: $74.99 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $463.93 | 2021-2023 | |
| Astellas Pharma US INC | $200.69 | 2023-2024 | Veozah |
| Biogen, INC. | $196.56 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $126.82 | 2021-2023 | Balcoltra |
| Myovant Sciences INC. | $124.64 | 2021 | |
| Daiichi Sankyo INC. | $94.19 | 2022 | |
| Organon LLC | $86.40 | 2021-2025 | Nexplanon |
| Davol INC. | $85.38 | 2025 | Arista |
| Cumberland Pharmaceuticals, INC. | $83.33 | 2025 | Kristalose |
| Shield Therapeutics INC | $66.10 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $36.91 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $28.23 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.44 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $23.51 | 2025 | Qelbree |
| Exeltis, USA INC. | $22.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivette Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.